Ovarian Cancer Clinical Trial

Imaging Study on Halcyon 4.0 System for Patients Receiving Radiation Therapy

Summary

This prospective imaging study is evaluating the feasibility of using the Halcyon 4.0 radiotherapy system for radiation therapy planning in patients with cancer. The Halcyon 4.0 system has been engineered to decrease the image acquisition time and the radiation exposure, but the system has not yet been clinically validated for use in radiation planning. This pilot study will evaluate images obtained on the Halcyon 4.0 system to assess if the quality is sufficient for radiation treatment plan construction.

View Eligibility Criteria

Eligibility Criteria

Eligibility Criteria:

Scheduled to receive radiation therapy to one of the following sites:

Head and neck/brain (n=10)
Thorax (n=10)
Abdomen (n=10)
Pelvis (n=10)
At least 18 years of age
If the patient will be receiving IV contrast on study: Adequate renal function as defined by a serum creatinine < 1.4, or, for patients with chronic kidney disease, a stable serum creatinine < 2.0. Note: if no IV contrast will be administered on study, patient may enroll without creatinine level documented.
If the patient is a woman of childbearing potential, a negative pregnancy test must be obtained. Contraceptive use is not an adequate documentation of no chance of pregnancy.
Able to understand and willing to sign an IRB approved written informed consent document.

Study is for people with:

Ovarian Cancer

Estimated Enrollment:

40

Study ID:

NCT05427214

Recruitment Status:

Recruiting

Sponsor:

Washington University School of Medicine

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Washington University School of Medicine
Saint Louis Missouri, 63110, United States More Info
Pamela Samson, M.D., MPHS
Contact
314-801-3806
[email protected]
Pamela Samson, M.D., MPHS
Principal Investigator
James Cordova, M.D.
Sub-Investigator
Tianyu Zhao, Ph.D.
Sub-Investigator
Lauren Henke, M.D., MSCI
Sub-Investigator
Alex Price, M.S.
Sub-Investigator
Hyun Kim, M.D.
Sub-Investigator
Hua Li, Ph.D.
Sub-Investigator
Eric Laugeman, M.S.
Sub-Investigator
Taeho Kim, Ph.D.
Sub-Investigator
Nels Knutson, Ph.D.
Sub-Investigator

How clear is this clinincal trial information?

Study is for people with:

Ovarian Cancer

Estimated Enrollment:

40

Study ID:

NCT05427214

Recruitment Status:

Recruiting

Sponsor:


Washington University School of Medicine

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.